Medvantx names new chief technology officer
8 January 2020 -

Medvantx Inc, a provider of ecommerce and final mile delivery solutions, has named Jeremy V Gross as its new chief technology officer, it was reported yesterday.

In the new role, Gross will focus on the further development of the company's proprietary ecommerce, pharmacy and final mile delivery platform. As CTO, Gross will lead Medvantx's newly created business unit dedicated to advancing the company's technology platform, and identify new technology-based solutions for the company's clients.

Gross has a track record of over 30 years leading development teams and leveraging emerging technologies to create disruptive innovation within biopharma, healthcare and the financial technology industries. Earlier, he held senior technology, innovation and incubation leadership roles at Amgen, McKesson, Intuit and JPMorgan. Gross has lead the design, development and commercialisation of e-commerce, complex back-end logistics systems and cloud-based data solutions for pharmaceutical and global distribution companies, and early online banking and e-Commerce platforms in financial services.